Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature

• Publication date

  2007-02-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature05529PMID 17251933PMCID PMC4601097
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Restoration of p53 function leads to tumour regression in vivo

  2007cited by this paper
• The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

  2006cited by this paper
• Correspondence and requests for materials should be addressed to:

  2006cited by this paper
• The pathological response to DNA damage does not contribute to p53-mediated tumour suppression

  2006cited by this paper
• Cellular senescence in naevi and immortalisation in melanoma: a role for p16?

  2006cited by this paper
• Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

  2006cited by this paper
• p53-Dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions

  2005cited by this paper
• IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

  2005cited by this paper
• BRAFE600-associated senescence-like cell cycle arrest of human naevi

  2005cited by this paper
• Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

  2005cited by this paper
• Oncogene-induced senescence as an initial barrier in lymphoma development

  2005cited by this paper
• Tumour biology: Senescence in premalignant tumours

  2005cited by this paper
• The p53 pathway: positive and negative feedback loops

  2005cited by this paper
• Probing tumor phenotypes using stable and regulated synthetic microRNA precursors

  2005cited by this paper
• Second-generation shRNA libraries covering the mouse and human genomes

  2005cited by this paper
• Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors.

  2005cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• Review Principles of Tumor Suppression Erties of " Classic " Tumor Suppressor Genes. First, They

  2004cited by this paper
• Intrinsic tumour suppression

  2004cited by this paper
• Involvement of TRAIL and its receptors in viral hepatitis

  2003cited by this paper
• Ras Induces Vascular Smooth Muscle Cell Senescence and Inflammation in Human Atherosclerosis

  2003cited by this paper
• Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.

  2003cited by this paper
• TP53 and liver carcinogenesis

  2003cited by this paper
• Tumor cell senescence in cancer treatment.

  2003cited by this paper
• Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC

  2002cited by this paper
• Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound

  2002cited by this paper
• Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging

  2001cited by this paper
• Microarray analysis of replicative senescence.

  1999cited by this paper
• Essential role for oncogenic Ras in tumour maintenance

  1999cited by this paper
• Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

  1997cited by this paper
• Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.

  1995cited by this paper

• Toward In Situ Dynamics of DNA-Bound Full-Length p53 Tetramer.

  2026cites this paper
• The battle against skin aging: Advances in natural anti-aging compounds and innovative delivery systems

  2026cites this paper
• Targeting Cellular Senescence: A New Therapeutic Axis in Chronic Liver Disease

  2026cites this paper
• Opportunities and challenges of targeting cGAS–STING in cancer

  2026cites this paper
• Senescent cells secrete chromatin components via senescence-associated extracellular particles

  2026cites this paper
• Cellular senescence in lung cancer immune microenvironment and senotherapeutic opportunities

  2026cites this paper
• Of Barriers and Loops-How Evolution Limits Most Cancer Risks to Older Ages.

  2026cites this paper
• The Immunogenicity of Human Senescent Cells Is Dependent on the Senescence Inducer and Cell Type

  2026cites this paper
• Targeting immunosenesence promotes clearance of senescent cells

  2025cites this paper
• P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapy.

  2025cites this paper
• Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer.

  2025cites this paper
• KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression

  2025cites this paper
• Synergistic effect of exogenous P53 and sodium butyrate on tumor cell survival

  2025cites this paper
• Chemotherapy-Induced Cellular Senescence: A Comprehensive Review of Clinical Methodologies and Treatment Outcomes

  2025cites this paper
• Senescent Cancer Cells in Immune Surveillance and Evasion: Mechanisms and Therapeutic Implications.

  2025cites this paper
• Immune surveillance of senescent cells in aging and disease

  2025cites this paper
• In vitro senescence and senolytic functional assays.

  2025cites this paper
• The activation of cGAS-STING pathway offers novel therapeutic opportunities in cancers

  2025cites this paper
• Targeting Senescence in Oncology: An Emerging Therapeutic Avenue for Cancer

  2025cites this paper
• Senolytic Interventions for Type 2 Diabetes: Current Evidence and Future Directions

  2025cites this paper
• NFATc1 facilitates hepatocellular carcinoma progression by regulating the senescence-associated secretory phenotype

  2025cites this paper
• Kinase suppressor of Ras 1 (KSR1) promotes liver carcinogenesis via activation of the RAS/RAF/MEK/ERK signaling pathway

  2025cites this paper
• The dual role of cellular senescence in tumor occurrence and development

  2025cites this paper
• Towards In Situ Dynamics of DNA-bound Full-Length p53 Tetramer

  2025cites this paper
• Mitochondrial priming in therapy-induced senescence: implications for CAR-T/NK immunosenolytic therapy

  2025cites this paper
• Senescence Reprogramming Unleashes Tumor Immune Surveillance via Coordinated Gene Modulation

  2025cites this paper
• Lactylation-driven KRT19 promotes non-small cell lung cancer progression by suppressing cellular senescence

  2025cites this paper
• Senescent cells secrete chromatin components via senescence-associated extracellular particles

  2025cites this paper
• Exploring the Molecular Mechanism and Role of Glutathione S-Transferase P in Prostate Cancer

  2025cites this paper
• Heterogeneity of Cellular Senescence: Subtype‐Specific Mechanisms and the Emerging Role of Plasma Membrane Damage

  2025cites this paper
• A bibliometric and visual analysis of the impact of senescence on tumor immunotherapy

  2025cites this paper
• A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• Design, synthesis, and activity evaluation of indole derivatives as potential stabilizers for p53 Y220C.

  2025cites this paper
• Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator

  2025cites this paper
• STAT3/TGFBI signaling promotes the temozolomide resistance of glioblastoma through upregulating glycolysis by inducing cellular senescence

  2025cites this paper
• Exercise alleviates osteoporosis by regulating the secretion of the Senescent Associated Secretory Phenotype.

  2025cites this paper
• SASP Modulation for Cellular Rejuvenation and Tissue Homeostasis: Therapeutic Strategies and Molecular Insights

  2025cites this paper
• Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway

  2025cites this paper
• Prolonged exposure to leisure screen time notably accelerates biological aging: Evidence from observational studies and genetic associations

  2025cites this paper
• Charting the regulatory landscape of TP53 on transposable elements in cancer

  2025cites this paper
• New Insights into the Role of Cellular Senescence and Its Therapeutic Implications in Ocular Diseases

  2025cites this paper
• Taurine Alleviates Pancreatic β‐Cell Senescence by Inhibition of p53 Pathway

  2025cites this paper
• KRAS withdrawal in Cholangiocarcinoma leads to immune infiltration and tumor regression

  2025cites this paper
• Multi-Omics Strategies to Decode the Molecular Landscape of Cellular Senescence.

  2025cites this paper
• Nanomaterials intervene in cell senescence to reinforce cancer therapy

  2025cites this paper
• The senescence-inhibitory p53 isoform Δ133p53α: enhancing cancer immunotherapy and exploring novel therapeutic approaches for senescence-associated diseases.

  2025cites this paper
• Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma

  2025cites this paper
• Immunoregulatory mechanisms in the aging microenvironment: Targeting the senescence-associated secretory phenotype for cancer immunotherapy

  2025cites this paper
• p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program

  2025cites this paper
• From Genome Guardian to Immune Modulator: The Expanding Roles of Tumor Suppressor p53

  2025cites this paper
• Targeting cellular senescence for cancer therapy.

  2025cites this paper
• Advances in Cancer Treatment Through Nanotheranostics and Emerging Therapies

  2025cites this paper
• Cellular senescence in the innervated niche modulates cancer-associated pain: an emerging therapeutic target?

  2025cites this paper
• CDKN1A and cellular senescence are associated with immune resistance in advanced lung adenocarcinoma

  2025cites this paper
• Exosomal Dynamics: Bridging the Gap Between Cellular Senescence and Cancer Therapy.

  2025cites this paper
• Senotherapeutics in Malignant Brain Cancer Therapy

  2025cites this paper
• Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics

  2025cites this paper
• SMARCA4 regulates the NK-mediated killing of senescent cells

  2025cites this paper
• Senotherapy: Implications for Transplantation.

  2025cites this paper
• Identification of CCNB1 as a biomarker for cellular senescence in hepatocellular carcinoma: a bioinformatics and experimental validation study

  2025cites this paper
• The context-dependent effect of cellular senescence: from embryogenesis and wound healing to aging.

  2025cites this paper
• Cellular Senescence in Liver Diseases: From Molecular Drivers to Therapeutic Targeting.

  2025cites this paper
• Macrophage barrier responses to oncogenic transformation.

  2025cites this paper
• The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities

  2025cites this paper
• Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects

  2025cites this paper
• Aging-Associated CASC15/hsa-miR-30c-5p/ SERPINE1 Axis Affects the Occurrence and Development of Gastric Cancer

  2025cites this paper
• Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study

  2025influential citation
• Inflammation and tumor immune escape in response to DNA damage.

  2025cites this paper
• Pharmacological rescue of mutant p53 triggers spontaneous tumor regression via immune responses

  2025cites this paper
• Pharmacological Modulation of Cellular Senescence: Implications for Breast Cancer Progression and Therapeutic Strategies.

  2025cites this paper
• Senescence-associated lineage-aberrant plasticity evokes T-cell-mediated tumor control

  2025cites this paper
• Postoperative metastatic Krukenberg tumors with ARID1A and KRAS mutations in a patient with gastric cancer treated with oxaliplatin and tegafur: A case report

  2025cites this paper
• Changing landscape of hematopoietic and mesenchymal cells and their interactions during aging and in age-related skeletal pathologies.

  2025cites this paper
• Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids.

  2025cites this paper
• Identification of Nitric Oxide Donating Dasatinib Derivatives with Intraocular Pressure Lowering and Senolytic Activities.

  2025cites this paper
• Modelling the spatiotemporal dynamics of senescent cells in wound healing, chronic wounds, and fibrosis

  2025cites this paper
• Senescence, NK cells, and cancer: navigating the crossroads of aging and disease

  2025cites this paper
• HIV-Tat upregulates the expression of senescence biomarkers in CD4+ T-cells

  2025cites this paper
• Senescent human fibroblasts have increased FasL expression and impair the tumor immune response

  2025cites this paper
• Exploring the double-edged role of cellular senescence in chronic liver disease for new treatment approaches.

  2025cites this paper
• Exploring the Therapeutic Mechanism of Artesunate Against Ulcerative Colitis via Network Pharmacology and Molecular Docking

  2025cites this paper
• γδ T Cells Target and Ablate Senescent Cells in Aging and Alleviate Pulmonary Fibrosis

  2025cites this paper
• Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1

  2025cites this paper
• The Central Role of Pin1 in Age-Related Cancer Signaling Pathways.

  2025cites this paper
• Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss-No Target Is Out of the Realm of Possibility.

  2025cites this paper
• A transcriptome-based human universal senescence index (hUSI) robustly predicts cellular senescence under various conditions

  2025cites this paper
• Future Perspectives in Senescence-Based Therapies for Head and Neck Cancer

  2025cites this paper
• The TP53 tumor suppressor gene: From molecular biology to clinical investigations

  2025cites this paper
• Senescence, aging and disease throughout the gastrointestinal system.

  2025cites this paper
• Cellular senescence in chronic obstructive pulmonary disease: Molecular mechanisms and therapeutic interventionsa.

  2025cites this paper
• Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications

  2025cites this paper
• Lycium barbarum Glycopeptide Inhibits Colorectal Cancer Cell Proliferation via Activating p53/p21 Pathway and Inducing Cellular Senescence

  2025cites this paper
• Stromal senescence contributes to age-related increases in cancer

  2025cites this paper
• Interfaces Between the DNA Damage Response and Anti-cancer Immunity.

  2025cites this paper
• Redefining senescence through hepatocyte fate changes in liver diseases.

  2025cites this paper
• The cell cycle inhibitor p21CIP1 is essential for irinotecan-induced senescence and plays a decisive role in re-sensitization of temozolomide-resistant glioblastoma cells to irinotecan.

  2024cites this paper
• Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer Treatment: Challenges and Perspectives

  2024cites this paper
• Lactiplantibacillus plantarum inhibited the growth of primary liver cancer by inducing early apoptosis and senescence, in vitro

  2024cites this paper
• Immune therapeutic strategies for the senescent tumor microenvironment

  2024cites this paper
• Emerging Role of the p53 Pathway in Modulating Natural Killer Cell Mediated Immunity.

  2024cites this paper